SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer

Journal of Molecular Medicine

Volumn 92, Issue 12, 2014, Pages 1257-1269

  Wang, Jun ^a,b   Zhou, Hong ^a   Han, Yong ^a   Liu, Xiulan ^a   Wang, Min ^a   Wang, Xin ^a   Yin, Guoxiao ^a   Li, Xu ^a   Xiang, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell growth; Methylation; Pancreatic cancer; Reg3A; SOCS3

Indexed keywords

DEOXYCYTIDINE; I KAPPA B; JANUS KINASE 2; PROTEIN; REGENERATING ISLET DERIVED PROTEIN 3 ALPHA; SMALL INTERFERING RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; LECTIN; PANCREATITIS-ASSOCIATED PROTEIN; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; EPITHELIUM CELL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; METHYLATION; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PLASMID; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR DIFFERENTIATION; UPREGULATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84919582083     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1184-8     Document Type: Article

References (30)

1. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620
2. Liu A, Liu Y, Li PK, Li C, Lin J (2011) LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. Anticancer Res 31:2029–2035
3. Hong SM, Park JY, Hruban RH, Goggins M (2011) Molecular signatures of pancreatic cancer. Arch Pathol Lab Med 135:716–727
4. Parikh A, Stephan AF, Tzanakakis ES (2012) Regenerating proteins and their expression, regulation and signaling. Biomol Concepts 3:57–70
5. Nata K, Liu Y, Xu L, Ikeda T, Akiyama T, Noguchi N, Kawaguchi S, Yamauchi A, Takahashi I, Shervani NJ et al (2004) Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III. Gene 340:161–170
6. Cavard C, Terris B, Grimber G, Christa L, Audard V, Radenen-Bussiere B, Simon MT, Renard CA, Buendia MA, Perret C (2006) Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene 25:599–608
7. Cui W, De Jesus K, Zhao H, Takasawa S, Shi B, Srikant CB, Liu JL (2009) Overexpression of Reg3 alpha increases cell growth and the levels of cyclin D1 and CDK4 in insulinoma cells. Growth Factors 27:195–202
8. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, Chan DW, Canto M, Lillemoe KD, Cameron JL et al (2002) Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 62:1868–1875
9. Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, Hruban RH, Goggins M (2005) Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod Pathol 18:779–787
10. Xie MJ, Motoo Y, Iovanna JL, Su SB, Ohtsubo K, Matsubara F, Sawabu N (2003) Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma. Digest Dis Sci 48:459–464
11. Atkinson GP, Nozell SE, Benveniste ET (2010) NF-kappaB and STAT3 signaling in glioma: Targets for future therapies. Expert Rev Neurother 10:575–586
12. Ernst M, Putoczki TL (2012) Stat3: linking inflammation to (gastrointestinal) tumourigenesis. Clin Exp Pharmacol Physiol 39:711–718
13. Folch-Puy E, Granell S, Dagorn JC, Iovanna JL, Closa D (2006) Pancreatitis-Associated Protein I Suppresses NF-KB Activation through a JAK/STAT-Mediated Mechanism in Epithelial Cells. J Immunol 176:3774–3779
14. Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, Tebar L, Hunt SP, Bayne R, Smith AJH et al (2007) Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 56:1091–1097
15. Wilop S, van Gemmeren TB, Lentjes MH, van Engeland M, Herman JG, Brummendorf TH, Jost E, Galm O (2011) Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma. Epigenetics 6:1047–1052
16. Fourouclas N, Li J, Gilby DC, Campbell PJ, Beer PA, Boyd EM, Goodeve AC, Bareford D, Harrison CN, Reilly JT et al (2008) Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders. Haematologica 93:1635–1644
17. Lindemann C, Hackmann O, Delic S, Schmidt N, Reifenberger G, Riemenschneider MJ (2011) SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. Acta Neuropathol 122:241–251
18. Pierconti F, Martini M, Pinto F, Cenci T, Capodimonti S, Calarco A, Bassi PF, Larocca LM (2011) Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate 71:318–325
19. Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C, Tannapfel A (2005) SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24:6699–6708
20. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, vander Woude CJ (2010) Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 59:227–235
21. Lin YC, Lin CK, Tsai YH, Weng HH, Li YC, You L, Chen JK, Jablons DM, Yang CT (2010) Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells. Oncol Rep 24:1605–1612
22. Molavi O, Wang P, Zak Z, Gelebart P, Belch A, Lai R (2013) Gene methylation and silencing of SOCS3 in mantle cell lymphoma. Brit J Haematol 161:348–356
23. Greer JB, Whitcomb DC (2009) Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol 9:411–418
24. Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39:425–435
25. Nagaraj NS, Smith JJ, Revetta F, Washington MK, Merchant NB (2010) Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Mol Cancer Ther 9:2322–2332
26. Ouyang H, Lj M, Luk C, Liu N, Karaskova J, Squire J, Tsao MS (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157:1623–1631
27. Zhang YW, Ding LS, Lai MD (2003) Reg gene family and human diseases. World J Gastroentero 9:2635–2641
28. He G, Karin M (2011) NF-kappaB and STAT3—Key players in liver inflammation and cancer. Cell Res 21:159–168
29. Pandurangan AK, Esa NM (2014) Signal transducer and activator of transcription 3—a promising target in colitis-associated cancer. Asian Pac J Cancer Prev 15:551–560
30. Cai H, Babic I, Wei X, Huang J, Witte ON (2011) Invasive prostate carcinoma driven by c-Src and androgen receptor synergy. Cancer Res 71:862–872